{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:02:52Z","timestamp":1781215372667,"version":"3.54.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,11]]},"DOI":"10.7759\/cureus.110684","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:43:26Z","timestamp":1781214206000},"source":"Crossref","is-referenced-by-count":0,"title":["Retroperitoneal and Pelvic Myeloid Sarcoma in a Patient With JAK2-Positive Polycythemia Vera: A Case Report"],"prefix":"10.7759","author":[{"given":"Mozhan M","family":"Hagigatian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Hatem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi J","family":"Hatem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri SA","year":"2007","unstructured":"Pileri SA, Ascani S, Cox MC, et al.. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007, 21:340-50. 10.1038\/sj.leu.2404491","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst RL","year":"2011","unstructured":"Bakst RL, Tallman MS, Douer D, Yahalom J. How I treat extramedullary acute myeloid leukemia. Blood. 2011, 118:3785-93. 10.1182\/blood-2011-04-347229","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.02.027","article-title":"Myeloid sarcoma: presentation, diagnosis, and treatment","volume":"17","author":"Almond LM","year":"2017","unstructured":"Almond LM, Charalampakis M, Ford SJ, Gourevitch D, Desai A. Myeloid sarcoma: presentation, diagnosis, and treatment. Clin Lymphoma Myeloma Leuk. 2017, 17:263-7. 10.1016\/j.clml.2017.02.027","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/2040620711410774","article-title":"Myeloid sarcoma: current approach and therapeutic options","volume":"2","author":"Avni B","year":"2011","unstructured":"Avni B, Koren-Michowitz M. Myeloid sarcoma: current approach and therapeutic options. Ther Adv Hematol. 2011, 2:309-16. 10.1177\/2040620711410774","journal-title":"Ther Adv Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP1ZA7HYZKAZHS","article-title":"Myeloid sarcoma: extramedullary manifestation of myeloid disorders","volume":"132","author":"Campidelli C","year":"2009","unstructured":"Campidelli C, Agostinelli C, Stitson R, Pileri SA. Myeloid sarcoma: extramedullary manifestation of myeloid disorders. Am J Clin Pathol. 2009, 132:426-37. 10.1309\/AJCP1ZA7HYZKAZHS","journal-title":"Am J Clin Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000497210","article-title":"Myeloid sarcoma","volume":"42","author":"Magdy M","year":"2019","unstructured":"Magdy M, Abdel Karim N, Eldessouki I, Gaber O, Rahouma M, Ghareeb M. Myeloid sarcoma. Oncol Res Treat. 2019, 42:224-9. 10.1159\/000497210","journal-title":"Oncol Res Treat"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v17.i1.113966","article-title":"Myeloid sarcoma transformed from myeloproliferative neoplasm: a case report and review of literature","volume":"17","author":"Zhong SH","year":"2026","unstructured":"Zhong SH, Lou J, Zhao AQ, Jin XL, Wei SM, Liang Y. Myeloid sarcoma transformed from myeloproliferative neoplasm: a case report and review of literature. World J Clin Oncol. 2026, 17:113966. 10.5306\/wjco.v17.i1.113966","journal-title":"World J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber DA","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, et al.. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022, 140:1200-28. 10.1182\/blood.2022015850","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00878-8","article-title":"Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm","volume":"13","author":"Tefferi A","year":"2023","unstructured":"Tefferi A, Alkhateeb H, Gangat N. Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm. Blood Cancer J. 2023, 13:108. 10.1038\/s41408-023-00878-8","journal-title":"Blood Cancer J"},{"key":"ref10","unstructured":"Myeloid sarcoma. Accessed. June 11, 2026: https:\/\/www.pathologyoutlines.com\/topic\/leukemiagranulocytic.html."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-014-0311-x","article-title":"Primary retroperitoneal masses: what is the differential diagnosis?","volume":"40","author":"Scali EP","year":"2015","unstructured":"Scali EP, Chandler TM, Heffernan EJ, Coyle J, Harris AC, Chang SD. Primary retroperitoneal masses: what is the differential diagnosis?. Abdom Imaging. 2015, 40:1887-903. 10.1007\/s00261-014-0311-x","journal-title":"Abdom Imaging"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000727","article-title":"Clinicopathological, cytogenetic, and prognostic analysis of 131 myeloid sarcoma patients","volume":"40","author":"Kawamoto K","year":"2016","unstructured":"Kawamoto K, Miyoshi H, Yoshida N, Takizawa J, Sone H, Ohshima K. Clinicopathological, cytogenetic, and prognostic analysis of 131 myeloid sarcoma patients. Am J Surg Pathol. 2016, 40:1473-83. 10.1097\/PAS.0000000000000727","journal-title":"Am J Surg Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104708","article-title":"Optimizing imaging modalities for sarcoma subtypes in radiation therapy: state of the art","volume":"211","author":"Beddok A","year":"2025","unstructured":"Beddok A, Kaur H, Khurana S, et al.. Optimizing imaging modalities for sarcoma subtypes in radiation therapy: state of the art. Crit Rev Oncol Hematol. 2025, 211:104708. 10.1016\/j.critrevonc.2025.104708","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/494208-retroperitoneal-and-pelvic-myeloid-sarcoma-in-a-patient-with-jak2-positive-polycythemia-vera-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:43:27Z","timestamp":1781214207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/494208-retroperitoneal-and-pelvic-myeloid-sarcoma-in-a-patient-with-jak2-positive-polycythemia-vera-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.110684","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,11]]}}}